Focused on developing and commercializing therapies for central nervous system disorders, the company markets drugs including Hetlioz for sleep-wake disorders and Fanapt for schizophrenia. Revenue is concentrated in a small portfolio of specialty pharmaceuticals, making regulatory decisions, patent ...
1 member of Congress has disclosed 1 trade in Vanda Pharmaceuticals Inc (VNDA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-06-15 | Rohit Khanna | sell | $1K – $15K |